Friday, March 17, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Defense + Military

Nano-Bio Manufacturing Consortium

by Global Biodefense Staff
November 16, 2012

The U.S. Air Force Research Laboratory (AFRL) is taking steps to establish a Nano-Bio Manufacturing Consortium (NBMC) of large and small companies, academia, federal laboratories, and defense acquisition centers to accelerate innovation in nano-bio manufacturing technologies. 

The NBMC effort is intended to accelerate risk assessment and the development of mitigation approaches for critical nano-bio materials and fabrication innovations by developing common technology and manufacturing platforms through public-private partnerships. 

A fully functioning NBMC will be established in two phases.  Phase 1 NBMC over the first 36 months will work to establish the most crucial public-private partnerships and coordinate their activity around a technical project that is driven by dual use commercial-military needs, and currently inhibited by high risk integration of nano-bio materials and manufacturing techniques.  

Phase II NBMC will leverage these successes to expand membership and potentially establish physical facilities as appropriate for the evolution of the consortium to span both virtual and physical bridges. 

A successful consortium will serve as a technical center of excellence, providing the infrastructure to support manufacturing enterprises at a prototype level that are relevant and scalable; and ensuring that the key capabilities for DoD needs is available. 

The Air Force intends to award a Department of Defense Grant and Agreement Regulations (DoDGARS) based Cooperative Agreement to a not-for-profit organization to spearhead Phase I NBMC. The award ceiling is $4.4M, of which the government share is $2.2M plus up to an additional $2.2M of a desired 50/50 recipient cost share. 

The effort is being developed under Broad Agency Announcement BAA-13-01-RQKD.

Tags: BAANanotech

Related Posts

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions
Pathogens

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
DARPA Selects Teams to Develop Vaccine Durability Prediction Model
Medical Countermeasures

DARPA Selects Teams to Develop Vaccine Durability Prediction Model

January 13, 2023
two soldiers are in head-to-toe hazmat suits with respirator masks while tending to a mannikin on a stretcher
CBRNE

Protection from Biothreats: DOD to Modernize Medical Countermeasures Development

January 10, 2023
The device appears smaller than a playing card, transparent, with visible channels branching off.
Medical Countermeasures

How Organ-on-a-chip Models Could Grease the Drug Development Pipeline

January 10, 2023
Load More

Latest News

Biodefense Headlines – 12 March 2023

Biodefense Headlines – 12 March 2023

March 12, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are okay with it.OkPrivacy policy